CLINICAL_TRIALS
approval
· 2025-12-15
Clinical Trial Update: Treatment on HBeAg Positive or HBeAg Negative in Chronic Hepatitis B
Summary
The update notes that a treatment for chronic hepatitis B, including patients regardless of HBeAg status, has been approved for marketing.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Nguyen Thi Trieu, MD | Conditions: CHRONIC HEPATITIS B | Status: APPROVED_FOR_MARKETING